Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study
Eom, Ki-Seong, Kim, Seok Jin, Lee, Je-Jung, Suh, Cheolwon, Kim, Jin Seok, Yoon, Sung-Soo, Kim, Byung Soo, Kang, Hye Jin, Choi, Young Jin, Kim, Chul Soo, Kim, Yang Soo, Kwak, Jae-Yong, Kim, Yoo Jin, JoVolume:
2014
Year:
2014
Language:
english
Journal:
BioMed Research International
DOI:
10.1155/2014/245247
File:
PDF, 227 KB
english, 2014